Miraculous Medicines and the Chemistry of Drug Design
Miraculous Medicines and the Chemistry of Drug Design
Keighley, Nathan
Taylor & Francis Ltd
08/2024
126
Mole
9780367644079
15 a 20 dias
Descrição não disponível.
Preface. A Brief Background. Finding a Target. Antibiotics: The Need for Innovation. Antiviral Agents and Rational Drug Design. The Fight Against Cancer. Targeting the Nervous System. Drug Design, Synthesis, and Development. Index.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Medicinal Chemists;Cancer chemotherapy;DNA Replication;Synthesise drugs;Neuraminidase Active Site;Medicinal chemistry;Steric Shield;Organic chemistry;Glycerol Side Chain;Antibiotics;Viral DNA Polymerase;C2 C3 Bond;Sialic Acid;Acyl Side Chain;Multidrug Approach;Antibody Drug Conjugate;Transpeptidase Enzyme;HIV Protease;Cholinergic Receptor;Anti-cancer Drugs;Non-covalent Interactions;Functional Group Interconversions;VSEPR;Amino Acid Side Chains;Beta Site Amyloid Precursor Protein Cleaving;Oestrogen Receptor;DNA Backbone;Pro-drug Approach;Anti-cancer Agents;Nucleoside Reverse Transcriptase Inhibitors
Preface. A Brief Background. Finding a Target. Antibiotics: The Need for Innovation. Antiviral Agents and Rational Drug Design. The Fight Against Cancer. Targeting the Nervous System. Drug Design, Synthesis, and Development. Index.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Medicinal Chemists;Cancer chemotherapy;DNA Replication;Synthesise drugs;Neuraminidase Active Site;Medicinal chemistry;Steric Shield;Organic chemistry;Glycerol Side Chain;Antibiotics;Viral DNA Polymerase;C2 C3 Bond;Sialic Acid;Acyl Side Chain;Multidrug Approach;Antibody Drug Conjugate;Transpeptidase Enzyme;HIV Protease;Cholinergic Receptor;Anti-cancer Drugs;Non-covalent Interactions;Functional Group Interconversions;VSEPR;Amino Acid Side Chains;Beta Site Amyloid Precursor Protein Cleaving;Oestrogen Receptor;DNA Backbone;Pro-drug Approach;Anti-cancer Agents;Nucleoside Reverse Transcriptase Inhibitors